Anatol J Cardiol. 2007; 7(3): 305-309
Cardiovascular side effects of newer antidepressants
Antony Fernandez1, Suji E. Bang2, Komandur Srivathsan2, W. Victor R. Vieweg11Psychiatry Service, Hunter Holmes McGuire Veterans Affairs Medical Center Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia
2Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
3Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
We review the cardiovascular effects of newer antidepressants. Although further studies are warranted, the safety of the selective serotonin reuptake inhibitors and the serotonin norepinephrine reuptake inhibitors on patients with comorbid cardiac conditions is impressive. Newer antidepressants should be considered as first-line agents for the treatment of depression in patients with and without cardiovascular disease.
Keywords: Antidepressant drugs, atrial fibrillation, blood pressure, bradycardia, cardiac death, cardiovascular effects, electrocardiogram, hypertension, hypotension, QT interval, ventricular premature beats, tachycardia
Yeni antidepresanların kardiyovasküler yan etkileri
Antony Fernandez1, Suji E. Bang2, Komandur Srivathsan2, W. Victor R. Vieweg11Psychiatry Service, Hunter Holmes McGuire Veterans Affairs Medical Center Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia
2Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
3Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
Anahtar Kelimeler: Antidepresan ajanlar, atriyal fibrilasyon, kan basıncı, bradikardi, kardiyak ölüm, kardiyovasküler etkileri, elektrokardi- yogram, hipertansiyon, hipotansiyon, QT aralığı, ventriküler ektopik vurular, taflikardi
Antony Fernandez, Suji E. Bang, Komandur Srivathsan, W. Victor R. Vieweg. Cardiovascular side effects of newer antidepressants. Anatol J Cardiol. 2007; 7(3): 305-309
Manuscript Language: English